-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on Haemonetics, Raises Price Target to $110

Benzinga·08/18/2026 13:49:39
Listen to the news
BTIG analyst Marie Thibault maintains Haemonetics (NYSE:HAE) with a Buy and raises the price target from $96 to $110.